Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells: Lessons from the antiphospholipid syndrome

Thrombosis and Haemostasis

Volumn 109, Issue 3, 2013, Pages 525-531

  Prinz, Nadine ^a   Clemens, Natascha ^a   Canisius, Antje ^a   Lackner, Karl J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Antiphospholipid antibodies; Endosome; NADPH oxidase; Thrombosis; Tissue factor factor VII

Indexed keywords

ACETYLCYSTEINE; ADALIMUMAB; CHLORIDE CHANNEL; FC RECEPTOR; GLUTATHIONE PEROXIDASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; NIFLUMIC ACID; PHOSPHOLIPID ANTIBODY; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSOME; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE FACTOR GENE; UPREGULATION;

ACETYLCYSTEINE; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; ENDOSOMES; ENDOTHELIAL CELLS; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MONOCYTES; NADPH OXIDASE; NIFLUMIC ACID; SUPEROXIDES; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874767596     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-06-0421     Document Type: Article

References (46)

1. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
2. Butenas S, et al. TF in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol 2009; 29: 1989-1996.
3. Camerer E, et al. Cell biology of TF, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
4. Drake TA, et al. Selective cellular expression of TF in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
5. Fleck RA, et al. Localization of human TF antigen by immunostaining with monospecific, polyclonal anti-human TF antibody. Thromb Res 1990; 59: 421-437.
6. Kuczynski J, et al. TF (TF) and TF pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obst Gynecol Rep Biol 2002; 105: 15-19.
7. Siegbahn A, et al. Binding of factor VIIa to TF on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood 2000; 96: 3452-3458.
8. Mandal SK, et al. Cellular localization and trafficking of TF. Blood 2006; 107: 4746-4753.
9. Erlich J, et al. TF is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci USA 1999; 96: 8138-8143.
10. Isermann B, et al. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 2003; 9: 331-337.
11. Pawlinski R, et al. Role of TF and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103: 1342-1347.
12. Ginsburg KS, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
13. Blank M, et al. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069-3073.
14. Pierangeli SS, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71: 670-674.
15. Boles J, Mackman N. Role of TF in thrombosis in antiphospholipid antibody syndrome. Lupus 2010; 19: 370-378.
16. Meroni PL, et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011; 7: 330-339.
17. Prinz N, et al. Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. Blood 2011; 118: 2322-2332.
18. von Landenberg C, et al. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. J Autoimmun 1999; 13: 215-223.
19. Lackner KJ, et al. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Thromb Haemost 2000; 83: 583-588.
20. Doring Y, et al. Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology 2010; 215: 230-241.
21. Prinz N, et al. Structural and functional characterization of a human IgG monoclonal antiphospholipid antibody. Immunobiology; 216: 145-151.
22. Wilson WA, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
23. Farmer-Boatwright MK, Roubey RA. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol 2009; 29: 321-325.
24. Meroni PL, et al. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol 2008; 34: 332-337.
25. Zhou H, et al. Characterization of monocyte TF activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004; 104: 2353-2358.
26. Crossman DC, et al. The regulation of TF mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-9787.
27. Donovan-Peluso M, et al. Lipopolysaccharide induction of TF expression in THP-1 monocytic cells. Protein-DNA interactions with the promoter. J Biol Chem 1994; 269: 1361-1369.
28. Moll T, et al. Regulation of the TF promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem 1995; 270: 3849-3857.
29. Simoncini S, et al. Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome. Int Immunol 2005; 17: 489-500.
30. DeCoursey TE, et al. The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 2003; 422: 531-534.
31. Miller FJ, Jr., et al. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res 2007; 101: 663-671.
32. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983; 52: 711-760.
33. Koczor CA, et al. Mitochondrial DNA damage initiates a cell cycle arrest by a Chk2-associated mechanism in mammalian cells. J Biol Chem 2009; 284: 36191-36201.
34. Babior BM, et al. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973; 52: 741-744.
35. Parchment RE. Programmed cell death (apoptosis) in murine blastocysts: extracellular free-radicals, polyamines, and other cytotoxic agents. In Vivo 1991; 5: 493-500.
36. Pierce GB, et al. Hydrogen peroxide as a mediator of programmed cell death in the blastocyst. Differentiation 1991; 46: 181-186.
37. Ferro D, et al. Enhanced monocyte expression of TF by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost 2003; 1: 523-531.
38. Poitevin S, et al. Type I collagen induces TF expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway. J Thromb Haemost 2008; 6: 1586-1594.
39. Herkert O, Gorlach A. Redox control of TF expression in smooth muscle cells and other vascular cells. Methods Enzymol 2002; 352: 220-231.
40. Schmidt KN, et al. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol 1995; 2: 13-22.
41. Oeth P, et al. Regulation of the TF gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 1997; 17: 365-374.
42. Schreck R, et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258.
43. Yeh SH, et al. Translational and transcriptional control of Sp1 against ischaemia through a hydrogen peroxide-activated internal ribosomal entry site pathway. Nucleic Acids Res 2011; 39: 5412-5423.
44. Manea A, et al. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol 2008; 28: 878-885.
45. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720.
46. Banfi C, et al. Mitochondrial reactive oxygen species: a common pathway for PAR1-and PAR2-mediated TF induction in human endothelial cells. J Thromb Haemost 2009; 7: 206-216.